Acetyl-L-Carnitine (ALCAR) and Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Acetyl-L-Carnitine (ALCAR)
The brain-penetrant carnitine — real evidence for diabetic neuropathy, softer signals for mood and aging cognition.
Grade B3 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging)
Evidence grade C — Modest
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Acetyl-L-Carnitine (ALCAR) | Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging) |
|---|---|---|
| Cognition (MCI/aging) | Evidence grade CSmall effectmixedModest | Evidence grade CSmall effectmixedModest |
Graded only in Acetyl-L-Carnitine (ALCAR)
- Diabetic neuropathy pain Moderate effectEvidence grade B
- Depression (older adults) Small effectEvidence grade B
Graded only in Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging)
None — every outcome it grades is graded in both.
What each entry says about the other
- Acetyl-L-Carnitine (ALCAR) for Cognition (MCI/aging)’s entry · Goes with: Read the full Acetyl-L-Carnitine (ALCAR) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.